Janus Henderson Group’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.1M | Buy |
5,503,349
+221,195
| +4% | +$2.9M | 0.04% | 322 |
|
|
2025
Q1 | $123M | Buy |
5,282,154
+298,214
| +6% | +$6.94M | 0.07% | 236 |
|
|
2024
Q4 | $133M | Buy |
4,983,940
+425,421
| +9% | +$11.4M | 0.07% | 246 |
|
|
2024
Q3 | $122M | Buy |
4,558,519
+1,951,220
| +75% | +$52.1M | 0.06% | 251 |
|
|
2024
Q2 | $46.9M | Buy |
2,607,299
+801,987
| +44% | +$14.4M | 0.03% | 392 |
|
|
2024
Q1 | $32.9M | Buy |
1,805,312
+590,299
| +49% | +$10.8M | 0.02% | 462 |
|
|
2023
Q4 | $13.2M | Buy |
1,215,013
+94,246
| +8% | +$1.03M | 0.01% | 623 |
|
|
2023
Q3 | $6.43M | Buy |
1,120,767
+540,019
| +93% | +$3.1M | ﹤0.01% | 758 |
|
|
2023
Q2 | $4.49M | Sell |
580,748
-189,051
| -25% | -$1.46M | ﹤0.01% | 892 |
|
|
2023
Q1 | $5.13M | Sell |
769,799
-650,070
| -46% | -$4.33M | ﹤0.01% | 863 |
|
|
2022
Q4 | $12.7M | Sell |
1,419,869
-1,666,143
| -54% | -$14.9M | 0.01% | 666 |
|
|
2022
Q3 | $30.4M | Buy |
3,086,012
+1,476,650
| +92% | +$14.5M | 0.01% | 601 |
|
|
2022
Q2 | $12.8M | Buy |
1,609,362
+176,046
| +12% | +$1.4M | 0.01% | 643 |
|
|
2022
Q1 | $13.9M | Sell |
1,433,316
-93,019
| -6% | -$902K | 0.01% | 826 |
|
|
2021
Q4 | $23.3M | Sell |
1,526,335
-205,688
| -12% | -$3.14M | 0.01% | 749 |
|
|
2021
Q3 | $27.6M | Sell |
1,732,023
-57,257
| -3% | -$913K | 0.01% | 712 |
|
|
2021
Q2 | $36.7M | Sell |
1,789,280
-351,628
| -16% | -$7.21M | 0.02% | 649 |
|
|
2021
Q1 | $65.1M | Buy |
+2,140,908
| New | +$65.1M | 0.03% | 475 |
|